Posted on Friday, 29 July 2011 by
WASHINGTON—A new multi-year study has now shown that using tacrolimus (TAC) and mycophenolate mofetil (MMF) in combination provided the best long-term benefits and the least amount of side effects after a kidney transplant, according to a study
Read the full article at Renal Business News Only Feed